<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:46:04Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9267956" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9267956</identifier>
        <datestamp>2022-07-09</datestamp>
        <setSpec>fcvm</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Front Cardiovasc Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Front Cardiovasc Med</journal-id>
              <journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
              <journal-title-group>
                <journal-title>Frontiers in Cardiovascular Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2297-055X</issn>
              <publisher>
                <publisher-name>Frontiers Media S.A.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9267956</article-id>
              <article-id pub-id-type="pmcid">PMC9267956</article-id>
              <article-id pub-id-type="pmc-uid">9267956</article-id>
              <article-id pub-id-type="pmid">35811715</article-id>
              <article-id pub-id-type="doi">10.3389/fcvm.2022.886689</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Cardiovascular Medicine</subject>
                  <subj-group>
                    <subject>Original Research</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Spaceflight-Associated Changes of snoRNAs in Peripheral Blood Mononuclear Cells and Plasma Exosomesâ€”A Pilot Study</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rai</surname>
                    <given-names>Amit Kumar</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/1120178/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rajan</surname>
                    <given-names>K. Shanmugha</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bisserier</surname>
                    <given-names>Malik</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/771821/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brojakowska</surname>
                    <given-names>Agnieszka</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/1487115/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sebastian</surname>
                    <given-names>Aimy</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/255095/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Evans</surname>
                    <given-names>Angela C.</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/1643233/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coleman</surname>
                    <given-names>Matthew A.</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/107598/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mills</surname>
                    <given-names>Paul J.</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Arakelyan</surname>
                    <given-names>Arsen</given-names>
                  </name>
                  <xref rid="aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/25209/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Uchida</surname>
                    <given-names>Shizuka</given-names>
                  </name>
                  <xref rid="aff8" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/25071/overview"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hadri</surname>
                    <given-names>Lahouaria</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/493636/overview"/>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Goukassian</surname>
                    <given-names>David A.</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <xref rid="c001" ref-type="corresp">
                    <sup>*</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Garikipati</surname>
                    <given-names>Venkata Naga Srikanth</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff9" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="c002" ref-type="corresp">
                    <sup>*</sup>
                  </xref>
                  <uri xlink:href="http://loop.frontiersin.org/people/1102401/overview"/>
                </contrib>
              </contrib-group>
              <aff id="aff1"><sup>1</sup><institution>Department of Emergency Medicine, The Ohio State University Wexner Medical Center</institution>, <addr-line>Columbus, OH</addr-line>, <country>United States</country></aff>
              <aff id="aff2"><sup>2</sup><institution>Department of Chemical and Structural Biology, Weizmann Institute of Science</institution>, <addr-line>Rehovot</addr-line>, <country>Israel</country></aff>
              <aff id="aff3"><sup>3</sup><institution>Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
              <aff id="aff4"><sup>4</sup><institution>Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory</institution>, <addr-line>Livermore, CA</addr-line>, <country>United States</country></aff>
              <aff id="aff5"><sup>5</sup><institution>Department of Radiation Oncology, University of California, Davis</institution>, <addr-line>Sacramento, CA</addr-line>, <country>United States</country></aff>
              <aff id="aff6"><sup>6</sup><institution>Center of Excellence for Research and Training in Integrative Health, University of California, San Diego</institution>, <addr-line>La Jolla, CA</addr-line>, <country>United States</country></aff>
              <aff id="aff7"><sup>7</sup><institution>Group of Bioinformatics, Institute of Molecular Biology, National Academy of Sciences of the Republic of Armenia</institution>, <addr-line>Yerevan</addr-line>, <country>Armenia</country></aff>
              <aff id="aff8"><sup>8</sup><institution>Center for RNA Medicine, Department of Clinical Medicine, Aalborg University</institution>, <addr-line>Copenhagen</addr-line>, <country>Denmark</country></aff>
              <aff id="aff9"><sup>9</sup><institution>Dorothy M. Davis Heart Lung and Research Institute, The Ohio State University Wexner Medical Center</institution>, <addr-line>Columbus, OH</addr-line>, <country>United States</country></aff>
              <author-notes>
                <fn fn-type="edited-by">
                  <p>Edited by: Francesca Mastorci, Italian National Research Council, Italy</p>
                </fn>
                <fn fn-type="edited-by">
                  <p>Reviewed by: Jes-niels Boeckel, University Hospital Leipzig, Germany; Tobias Jakobi, University of Arizona, United States</p>
                </fn>
                <corresp id="c001">*Correspondence: David A. Goukassian, <email>david.goukassian@mssm.edu</email></corresp>
                <corresp id="c002">Venkata Naga Srikanth Garikipati, <email>venkata.garikipati@osumc.edu</email></corresp>
                <fn fn-type="other" id="fn004">
                  <p>This article was submitted to General Cardiovascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>6</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>9</volume>
              <elocation-id>886689</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>6</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright Â© 2022 Rai, Rajan, Bisserier, Brojakowska, Sebastian, Evans, Coleman, Mills, Arakelyan, Uchida, Hadri, Goukassian and Garikipati.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Rai, Rajan, Bisserier, Brojakowska, Sebastian, Evans, Coleman, Mills, Arakelyan, Uchida, Hadri, Goukassian and Garikipati</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
                </license>
              </permissions>
              <abstract>
                <p>During spaceflight, astronauts are exposed to various physiological and psychological stressors that have been associated with adverse health effects. Therefore, there is an unmet need to develop novel diagnostic tools to predict early alterations in astronautsâ€™ health. Small nucleolar RNA (snoRNA) is a type of short non-coding RNA (60â€“300 nucleotides) known to guide 2â€²-O-methylation (Nm) or pseudouridine (Ïˆ) of ribosomal RNA (rRNA), small nuclear RNA (snRNA), or messenger RNA (mRNA). Emerging evidence suggests that dysregulated snoRNAs may be key players in regulating fundamental cellular mechanisms and in the pathogenesis of cancer, heart, and neurological disease. Therefore, we sought to determine whether the spaceflight-induced snoRNA changes in astronautâ€™s peripheral blood (PB) plasma extracellular vesicles (PB-EV) and peripheral blood mononuclear cells (PBMCs). Using unbiased small RNA sequencing (sRNAseq), we evaluated changes in PB-EV snoRNA content isolated from astronauts (<italic>n</italic> = 5/group) who underwent median 12-day long Shuttle missions between 1998 and 2001. Using stringent cutoff (fold change &gt; 2 or log<sub>2</sub>-fold change &gt;1, FDR &lt; 0.05), we detected 21 down-and 9â€”up-regulated snoRNAs in PB-EVs 3 days after return (R + 3) compared to 10 days before launch (L-10). qPCR validation revealed that SNORA74A was significantly down-regulated at R + 3 compared to L-10. We next determined snoRNA expression levels in astronautsâ€™ PBMCs at R + 3 and L-10 (<italic>n</italic> = 6/group). qPCR analysis further confirmed a significant increase in SNORA19 and SNORA47 in astronautsâ€™ PBMCs at R + 3 compared to L-10. Notably, many downregulated snoRNA-guided rRNA modifications, including four Nms and five Ïˆs. Our findings revealed that spaceflight induced changes in PB-EV and PBMCs snoRNA expression, thus suggesting snoRNAs may serve as potential novel biomarkers for monitoring astronautsâ€™ health.</p>
              </abstract>
              <kwd-group>
                <kwd>snoRNA</kwd>
                <kwd>biomarker</kwd>
                <kwd>astronaut</kwd>
                <kwd>extracellular vesicles</kwd>
                <kwd>peripheral bloodâ€”mononuclear cells</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source id="cn001">
                    <institution-wrap>
                      <institution>National Aeronautics and Space Administration</institution>
                      <institution-id institution-id-type="doi">10.13039/100000104</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id award-type="contract" rid="cn001">80NSSC19K1079</award-id>
                  <award-id award-type="contract" rid="cn001">FIP0005</award-id>
                </award-group>
                <award-group>
                  <funding-source id="cn002">
                    <institution-wrap>
                      <institution>American Heart Association</institution>
                      <institution-id institution-id-type="doi">10.13039/100000968</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id award-type="contract" rid="cn002">18CDA34110277</award-id>
                  <award-id award-type="contract" rid="cn002">915681</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="1"/>
                <equation-count count="0"/>
                <ref-count count="44"/>
                <page-count count="7"/>
                <word-count count="4598"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="S1">
              <title>Introduction</title>
              <p>During spaceflight, astronauts are exposed to various physiological and psychological stressors, such as microgravity, sleep deprivation, isolation, confinement, and high ionizing radiation (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Despite the risk mitigation plans currently in place, it is anticipated that these stressors will have more prominent adverse health effects during deep-space exploration missions, including but not limited to loss of muscle mass, immune cell dysfunction, neurodegeneration, cancers, and cardiovascular diseases (CVDs). Therefore, space travel-associated adverse health conditions remain a considerable concern for astronauts (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Consequently, there is an unmet need to develop novel diagnostic tools to predict early alterations in astronautsâ€™ health.</p>
              <p>Extracellular vesicles (EVs) are secreted from most cells and are enriched in different non-coding RNA (ncRNA) species which serve as significant drivers of intracellular communication in physiology and pathological conditions (<xref rid="B5" ref-type="bibr">5</xref>â€“<xref rid="B7" ref-type="bibr">7</xref>). The mechanism of action of EV-mediated molecular signaling primarily includes the transfer of the exosomal cargo (e.g., parent cell-specific ncRNAs) to target cells (<xref rid="B8" ref-type="bibr">8</xref>), resulting in the dysregulation of various biological processes (<xref rid="B9" ref-type="bibr">9</xref>). Several RNA species, including mRNA, miRNA, lncRNA and other ncRNAs, are identified in the EV cargo, of which miRNA is the most characterized (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B9" ref-type="bibr">9</xref>â€“<xref rid="B12" ref-type="bibr">12</xref>). The long-standing assumption that snoRNAs function as housekeeping genes has been challenged in recent years, unveiling their likely utility as predictive biomarkers for a wide variety of diseases (<xref rid="B13" ref-type="bibr">13</xref>â€“<xref rid="B15" ref-type="bibr">15</xref>). Small nucleolar RNAs (snoRNAs) are a class of short ncRNAs (60â€“300 nucleotides) usually located in the nucleus of eukaryotic organisms. Typically, most snoRNAs are generated co-transcriptionally with a host gene, followed by splicing, branching of the intron lariat, and exonucleolytic digestion in the nucleoplasm (<xref rid="B16" ref-type="bibr">16</xref>). snoRNA carry either C/D or H/ACA motifs. C/D snoRNAs typically contain C/D box motifs (C: RUGAUGA and D: CUGA) that recruit proteins vital to forming the 2â€²-O-methyltransferase complexes, including fibrillarin in eukaryotes (NOP1 in yeast). H/ACA snoRNA contain H and ACA motifs (H: ANANNA and ACA) and participate in pseudouridylation by recruiting a pseudouridine synthase enzyme dyskerin in eukaryotes (Cbf5 in yeast) to the target RNA (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). snoRNA are known to guide 2â€²-O-methylation (Nm) or pseudouridine (Ïˆ) on rRNA, snRNA, or mRNA (<xref rid="B19" ref-type="bibr">19</xref>). Over recent years, snoRNAs have gained increasing interest among the scientific community. Emerging evidence suggests that dysregulation of snoRNAs may be key players in regulating fundamental cellular mechanisms and the pathogenesis of diabetes, cancer, CVDs, and neurological disease; thus, snoRNAs may prove to be potential biomarkers for detecting human diseases (<xref rid="B20" ref-type="bibr">20</xref>â€“<xref rid="B24" ref-type="bibr">24</xref>). The present study aimed to assess the effects of spaceflight on astronauts, peripheral blood (PB) plasma EVs (PB-EVs) snoRNA content and describe the differential expression of spaceflight-induced snoRNAs in astronaut peripheral blood mononuclear cells (PBMCs).</p>
            </sec>
            <sec sec-type="materials|methods" id="S2">
              <title>Materials and Methods</title>
              <sec id="S2.SS1">
                <title>Astronaut Samples</title>
                <p>This study was determined to be a non-human study by NASAâ€™s Institutional Review Board (IRB) and the Icahn School of Medicine at Mount Sinaiâ€™s IRB (STYDY00000075 and HSM19-00367, respectively). Samples were collected as part of a NASA flight study (<xref rid="B25" ref-type="bibr">25</xref>). All participants provided written informed consent to have blood stored and used for retrospective analysis. PB was sampled 10 days before launch (L-10) and 3 days after return (R + 3) from five astronauts (S12, S30, S31, S34, and S39) who flew short (median 12 day long) Shuttle missions between 1998 and 2001. De-identified blood samples were stored at âˆ’80Â°C until use.</p>
              </sec>
              <sec id="S2.SS2">
                <title>Thrombin Plasma Preparation for Extracellular Vesicle Precipitation</title>
                <p>Exosomes were isolated from blood plasma samples of five astronauts (S12, S30, S31, S34, and S39) at L-10 and R + 3 using the ExoQuick Plasma prep and Exosome precipitation kit (Cat # EXOQ5TM, System Biosciences, CA, United States), as previously described (<xref rid="B26" ref-type="bibr">26</xref>). Briefly, thrombin was added to the plasma and incubated for 5 min at room temperature (RT). Next, samples were centrifuged at 10,000 rpm for 5 min, and the supernatant was incubated with the exosome precipitation solution for 30 min at 4Â°C. Next, samples were centrifuged for 30 min at 1,500 Ã— <italic>g</italic> at 4Â°C. Finally, the supernatant was aspirated, and the beige-colored pellet was dissolved in 100 Î¼l of sterile 1Ã— PBS.</p>
              </sec>
              <sec id="S2.SS3">
                <title>RNA Isolation</title>
                <p>According to the manufacturerâ€™s protocol, total RNA was extracted from astronaut-derived exosomes using PB collected at L-10 and R + 3 using the RNeasy Mini Kit (Qiagen). High-quality RNA was isolated using RNeasy Mini spin columns and eluted using molecular-grade water (RNAse/DNAse free). All samples first undergo quality control assessment to ensure successful library preparation and sequencing. RNA sample quality was assessed by NanoDrop and Agilent 2100 BioAnalyzer. Samples with RNA integrity number (RIN) above 7, OD260/280: 2, and OD260/230 â‰¥ 2 were used. In addition, RNA degradation and contamination were monitored on 1% agarose gels before small RNA sequencing (sRNAseq).</p>
              </sec>
              <sec id="S2.SS4">
                <title>Library Preparation and Small RNA Sequencing</title>
                <p>RNA quality was assessed using an Agilent TapeStation (Agilent, Palo Alto, CA, United States), and RNA concentration was quantified by Qubit 4.0 spectrophotometer. The library for sRNAseq was prepared using the Smarter smRNA-seq kit for Illumina (Takara Bio Inc., United States). The quantity and quality of amplified libraries were evaluated using Qubit (Invitrogen, Carlsbad, CA, United States) and Agilent TapeStation high sensitivity D1000 Screen Tape. sRNAseq libraries were sequenced using single-end 75 base pairs sequencing chemistry on NextSeq 500 instruments following the manufacturerâ€™s protocols (Illumina).</p>
              </sec>
              <sec id="S2.SS5">
                <title>Real-Time Quantitative Reverse Transcription PCR</title>
                <p>We isolated total RNA from EVs isolated from PB of independent cohort (astronauts S3, S13, S6) and PBMCs (astronauts S7, S8, S12, S22, S23, S24) at L-10 and R + 3. According to the manufacturerâ€™s protocol, cDNA synthesis was performed with total RNA using the cDNA synthesis kit (Cat # 4368813, Applied BioSystems, Waltham, MA, United States). Real-time polymerase chain reaction (RT-qPCR) was performed using TaqMan probes (Master Mix, Cat #4444963, Applied BioSystems, Waltham, MA, United States) and QuantStudioâ„¢ three Real-Time PCR systems as recommended by the manufacturer. We measured the expression of the following snoRNAs indicated below.</p>
                <table-wrap position="float" id="d95e396">
                  <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
                    <tbody>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">SNORA74A</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">Hs03298571_s1</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">SCARNA1</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">Hs03298705_s1</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">SNORA19</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">Hs03457523_s1</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">SNORA47</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">Hs03309497_s1</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1">U6 snRNA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">Forward Primer: 5â€²-CTCGCTTCGGCAGCACA</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">Probe: 5â€²-ACGATACAGAGAAGATTAGCATGGCCC</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1">Reverse Primer: 5â€²-CGCTTCACGAATTTGCGTGTC</td>
                      </tr>
                    </tbody>
                  </table>
                </table-wrap>
              </sec>
              <sec id="S2.SS6">
                <title>Sequencing Data Analysis</title>
                <p>Sequencing data were processed with Cutadapt (<xref rid="B27" ref-type="bibr">27</xref>) to remove adapter sequences, and read quality was assessed with FastQC<sup><xref rid="footnote1" ref-type="fn">1</xref></sup>. Subsequently, reads were mapped with Bowtie (<xref rid="B28" ref-type="bibr">28</xref>) to the human genome (hg38), and gene count data were generated using featureCounts (<xref rid="B29" ref-type="bibr">29</xref>). Then, we used RUVSeq (<xref rid="B30" ref-type="bibr">30</xref>) to correct for batch effects and other unwanted variations. Differentially expressed genes were then identified with edgeR (<xref rid="B31" ref-type="bibr">31</xref>). Genes with false discovery rate adjusted <italic>p</italic>-value (FDR) &lt; 0.05 and log<sub>2</sub> fold change (FC) &gt; 1 were considered significantly differentially expressed genes. Subsequently, we extracted differentially expressed snoRNAs and generated a heatmap using custom R scripts.</p>
              </sec>
              <sec id="S2.SS7">
                <title>3D Structural Representation in Ribosomes</title>
                <p>The cryo-EM atomic models of human 80S ribosomes (PDB ID: 6EKO) were used to represent modified nucleotides (<xref rid="B32" ref-type="bibr">32</xref>). Figures were generated using UCSF Chimera-X software<sup><xref rid="footnote2" ref-type="fn">2</xref></sup>.</p>
                <sec id="S2.SS7.SSS1">
                  <title>Statistical Analysis of qRT-PCR Results</title>
                  <p>Results are presented as mean Â± standard error of the mean (SEM). Data were analyzed using an unpaired <italic>t</italic>-test for comparisons between means. Statistical analysis was performed using GraphPad Prism 9, version 9.2.0 (GraphPad Software, Inc., La Jolla, CA, United States). Differences were considered statistically significant at <italic>p</italic> &lt; 0.05.</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="results" id="S3">
              <title>Results</title>
              <p>This report shows the existence of snoRNAs in the PB-EV of astronauts for the first time. After the quality and quantity of EVs were validated by NanoSight and exosome specific protein array as described previously (<xref rid="B26" ref-type="bibr">26</xref>), we further characterized the snoRNA profile in PB-EVs by sRNAseq. Computational analysis revealed differential expression of snoRNAs in the PB-EVs collected 10 days before mission launch (L-10) compared to 3 days after landing (R + 3) from five astronauts who flew short duration (median 12 days long) Shuttle missions between 1998 and 2001 (<xref rid="F1" ref-type="fig">Figure 1A</xref>). The changes in PB-EV-derived snoRNA levels may be attributed to the expression of snoRNAs from the donor cells. Using stringent cutoff (FC &gt; 2, FDR &lt; 0.05 and <italic>p</italic> &lt; 0.01), we detected 21 down-regulated snoRNAs and 9 upregulated snoRNAs in PB-EVs at R + 3 compared to L-10. Next, we assessed the top four down-regulated snoRNAs (SNORA74A, SCARNA1, SNORA19, and SNORA47) by RT-qPCR analysis in three independent astronauts (S3, S13, and S6). However, only SNORA74A was detectable in the L-10 PB-EVs, whereas SCARNA1, SNORA19, and SNORA47 levels were undetectable in R + 3 and L-10 PB-EVs. Consistent with the sRNAseq results, we found that SNORA74A was significantly down-regulated at R + 3 compared to L-10 (<xref rid="F1" ref-type="fig">Figure 1B</xref>). Further, we validated the PCR products on 2% agarose gel and SNORA74A was undetectable in R + 3 compared to L-10 (<xref rid="FS1" ref-type="supplementary-material">Supplementary Figure 1</xref>). Given snoRNA modulation in the PB-EVs in the sRNAseq analysis, we speculated they could be detected in the astronautsâ€™ PBMCs. Surprisingly, RT-qPCR analysis confirmed a significant increase in SNORA19, SNORA47, whereas SCARNA1 and SNOR74A remained unchanged at R + 3 (<xref rid="F2" ref-type="fig">Figure 2</xref>). Given snoRNAs are known to guide 2â€²-<italic>O</italic>-methylation (Nm) or pseudouridine (Ïˆ) on rRNA, snRNA, or mRNA (<xref rid="B33" ref-type="bibr">33</xref>), we further examined the post-transcriptional modifications that were affected. Remarkably, we observed that many of the downregulated snoRNAs guided 9 rRNA modifications, including four Nms and five Ïˆs (<xref rid="TS1" ref-type="supplementary-material">Supplementary Table 1</xref>). Notably, some of these regulated snoRNAs guide adjacent positions in the rRNA, such as Ïˆ3730<italic>-</italic>Am3724 and Ïˆ3762<italic>-</italic>Ïˆ3764, which may suggest the existence of coordinated regulation of rRNA modifications. We also observed that these snoRNAs guided modifications in critical functional domains of ribosomes, such as Cm1272 (in close proximity to the decoding center), Ïˆ3762, and Ïˆ3764 (in the helix-H69 inter-subunit domain) (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p>
              <fig position="float" id="F1">
                <label>FIGURE 1</label>
                <caption>
                  <p>Small RNA sequencing of EV-derived RNA content. (A) Heat map of snoRNAs differentially expressed (fold change &gt; 2 and FDR &lt; 0.05) in the EVs derived from peripheral blood (PB) plasma collected 10 days before the launch (L-10) and 3 days after landing (R + 3) from five astronauts who flew Shuttle missions between 1998 and 2001 (<italic>n</italic> = 5 astronauts per group). (B) Validation of differentially expressed <italic>SNORA74A</italic> by RT-qPCR, normalized to <italic>U6</italic> snRNA, <italic>n</italic> = 3 astronauts/group. Data are presented as mean Â± SEM, <sup>**</sup><italic>p</italic> &lt; 0.01 vs. L-10 (two-sided unpaired students <italic>t</italic>-test).</p>
                </caption>
                <graphic xlink:href="fcvm-09-886689-g001" position="float"/>
              </fig>
              <fig position="float" id="F2">
                <label>FIGURE 2</label>
                <caption>
                  <p>Validation of PBMC snoRNA by RT-qPCR. Validation of differentially expressed snoRNAs in the RNA from PB mononuclear cells (PBMCs) collected L-10 and R + 3 from six astronauts by RT-qPCR, normalized to <italic>U6</italic> snRNA (<italic>n</italic> = 6 astronauts/group), including (A) SNORA19, (B) SNORA47, (C) SCARNA1, (D) SNORA74A. Data are presented as mean Â± SEM vs. L-10 (two-sided unpaired students <italic>t</italic>-test).</p>
                </caption>
                <graphic xlink:href="fcvm-09-886689-g002" position="float"/>
              </fig>
              <fig position="float" id="F3">
                <label>FIGURE 3</label>
                <caption>
                  <p>Deregulated snoRNAs guide specific rRNA modifications on human ribosome. Nm sites are indicated in red and Ïˆ sites are indicated in green, respectively. The identity of snoRNA guiding each modification is shown. The peptidyl transferase center (PTC), E site tRNA, decoding center (DC), and helix H69 are indicated. The large subunit (LSU), small subunit (SSU), and 5.8S rRNA are colored in gray, blue, and brown, respectively. The 3D representation is based on the published CryoEM structure of the human 80S ribosome (PDB 6EK0) (<xref rid="B32" ref-type="bibr">32</xref>).</p>
                </caption>
                <graphic xlink:href="fcvm-09-886689-g003" position="float"/>
              </fig>
              <p>In summary, our study revealed for the first time dysregulation of snoRNAs in PB-EVs and PBMCs from astronauts, blood after a relatively short (median 12 days long) Shuttle missions and underscored the potential translational value of investigating snoRNAs as biomarkers for monitoring astronauts health.</p>
            </sec>
            <sec sec-type="discussion" id="S4">
              <title>Discussion</title>
              <p>This study examined the snoRNA content and space-travel associated changes in their expression in EVs derived from the peripheral blood of five astronauts who flew relatively short (median 12 days long) space Shuttle missions between 1998 and 2001. We provide the first report showing differential snoRNAs packaging in the astronautsâ€™ plasma derived EVs pre- and post-flight.</p>
              <p>Emerging evidence suggests snoRNAâ€™s involvement in metabolism, diabetes, cancer, and heart development (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B34" ref-type="bibr">34</xref>). Specifically, dysregulation of SNORA47, SNORA74A, and SNORNA19 was previously described to be differentially expressed in different cancers (<xref rid="B35" ref-type="bibr">35</xref>â€“<xref rid="B37" ref-type="bibr">37</xref>). Further, SNORA74A was differentially expressed in the myocardium derived from infants with tetralogy of Fallot (<xref rid="B38" ref-type="bibr">38</xref>). In corroboration with these published studies, our data showed that SNORA47, SNORA74A, and SNORA19 were differentially expressed at 3 days post return from mission (R + 3) compared to baseline (L-10). These analyses provide a starting point for future studies to evaluate the predictive value of snoRNA packaging in PB-EVs or PBMCs in astronauts, who may be at risk of developing cancer or CVD.</p>
              <p>Recent evidence has supported the notion that rRNA modifications such as Nm and Î¨ guided by snoRNAs play an important role in translation by altering ribosome splicing and influencing snRNAs and mRNA stability by altering the binding of RNA-binding proteins (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>). In this study, we also observed that some of the dysregulated snoRNAs guide RNA modifications in critical functional domains of the ribosome, such as Cm1272 (in close proximity to the decoding center) and Î¨3762-Î¨3764 (in the helix-H69 inter-subunit domain). rRNA modification in these domains was previously suggested to be involved in translational regulation (<xref rid="B41" ref-type="bibr">41</xref>â€“<xref rid="B43" ref-type="bibr">43</xref>). Intriguingly, previous quantitative analysis of Nm suggested that Gm3744 (i.e., Gm3723) is highly variable in breast cancer patients (<xref rid="B44" ref-type="bibr">44</xref>). Notably, some of the differentially expressed snoRNAs identified in this study guide adjacent positions in the rRNA, such as Î¨3730-Am3724 and Î¨3762- Y3764, raising an intriguing coordinated regulation of rRNA modification. A more recent study demonstrated the contribution of a single rRNA modification toward generating ribosomes with specialized functions (<xref rid="B34" ref-type="bibr">34</xref>). Future functional studies are warranted to address the functional role of these specific RNA modifications in translation.</p>
              <p>In summary, our study reports for the first time a dysregulation of snoRNAs in PB-EVs and PBMCs from astronautsâ€™ blood after a relatively short (median 12 days long) Shuttle mission. Thus far, there is no reported evidence of CVD, cancer, or neurodegenerative diagnoses within this given astronaut cohort after approximately two decades. Albeit several limitations, the most considerable limitation of this study is the small sample size due to the rarity of access to astronautsâ€™ PB; despite this limitation, this study demonstrates the feasibility of utilizing retrospectively collected and bio-banked samples for the assessment of EV snoRNA alterations. Furthermore, it highlights the need for further retrospective and prospective longitudinal studies paired with clinical data to assess the utility and validity of the potential translational value of snoRNAs as biomarkers to predict astronautsâ€™ health and/or disease.</p>
            </sec>
            <sec sec-type="data-availability" id="S5">
              <title>Data Availability Statement</title>
              <p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: GEO, <ext-link xlink:href="GSE200079" ext-link-type="DDBJ/EMBL/GenBank">GSE200079</ext-link>.</p>
            </sec>
            <sec id="S6">
              <title>Ethics Statement</title>
              <p>This study was approved by NASA and Icahn School of Medicine at Mount Sinaiâ€™s Institutional Review Board (STUDY00000075 and HSM19-00367, respectively). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</p>
            </sec>
            <sec id="S7">
              <title>Author Contributions</title>
              <p>DAG, AKR, and VNSG designed the research. AKR, MB, AB, AS, and AE performed the research. AKR, MB, AB, AS, AE, MC, and SU analyzed the data. DAG, AKR, KSR, MB, AB, LH, and VNSG wrote the manuscript. All authors approved the manuscript.</p>
            </sec>
            <sec sec-type="COI-statement" id="conf1">
              <title>Conflict of Interest</title>
              <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
            </sec>
            <sec sec-type="disclaimer" id="pudiscl1">
              <title>Publisherâ€™s Note</title>
              <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
            </sec>
          </body>
          <back>
            <sec sec-type="funding-information" id="S8">
              <title>Funding</title>
              <p>This work was supported by the Translational Research Institute for Space Health FIP0005 and National Aeronautics and Space Administration grant 80NSSC19K1079 to DAG. This work was also partially supported by American Heart Association Career Development Award 18CDA34110277 and startup funds from the Ohio State University Medical Center to VNSG. AKR was supported with the American Heart Association-Post Doctoral Fellowship grant 915681. KSR was supported by Koshland Foundation and Dean of Chemistry, Postdoctoral Excellence Fellowship. Work was also performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344.</p>
            </sec>
            <fn-group>
              <fn id="footnote1">
                <label>1</label>
                <p>
                  <ext-link xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/" ext-link-type="uri">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>
                </p>
              </fn>
              <fn id="footnote2">
                <label>2</label>
                <p>
                  <ext-link xlink:href="https://www.rbvi.ucsf.edu/chimerax/" ext-link-type="uri">https://www.rbvi.ucsf.edu/chimerax/</ext-link>
                </p>
              </fn>
            </fn-group>
            <sec sec-type="supplementary-material" id="S9">
              <title>Supplementary Material</title>
              <p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2022.886689/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fcvm.2022.886689/full#supplementary-material</ext-link></p>
              <supplementary-material id="TS1" position="float" content-type="local-data">
                <media xlink:href="Table_1.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="FS1" position="float" content-type="local-data">
                <label>Supplementary Figure 1</label>
                <caption>
                  <p>Agarose gel electrophoresis of qPCR products. (A) SNORA74A PCR product was on run on 2% agarose gel (expected amplicon size: 69 nucleotides). (B) U6 snRNA was run on 2% agarose gel electrophoresis (expected amplicon size: 92 nucleotides).</p>
                </caption>
                <media xlink:href="Image_1.TIF">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="B1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezdan</surname><given-names>D</given-names></name><name><surname>Grigorev</surname><given-names>K</given-names></name><name><surname>Meydan</surname><given-names>C</given-names></name><name><surname>Pelissier Vatter</surname><given-names>FA</given-names></name><name><surname>Cioffi</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cell-free DNA (cfDNA) and exosome profiling from a year-long human spaceflight reveals circulating biomarkers.</article-title><source><italic>iScience.</italic></source> (<year>2020</year>) <volume>23</volume>:<issue>101844</issue>. <pub-id pub-id-type="doi">10.1016/j.isci.2020.101844</pub-id>
<?supplied-pmid 33376973?><pub-id pub-id-type="pmid">33376973</pub-id></mixed-citation>
              </ref>
              <ref id="B2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garikipati</surname><given-names>VNS</given-names></name><name><surname>Arakelyan</surname><given-names>A</given-names></name><name><surname>Blakely</surname><given-names>EA</given-names></name><name><surname>Chang</surname><given-names>PY</given-names></name><name><surname>Truongcao</surname><given-names>MM</given-names></name><name><surname>Cimini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Long-term effects of very low dose particle radiation on gene expression in the heart: degenerative disease risks.</article-title><source><italic>Cells.</italic></source> (<year>2021</year>) <volume>10</volume>:<issue>387</issue>. <pub-id pub-id-type="doi">10.3390/cells10020387</pub-id>
<?supplied-pmid 33668521?><pub-id pub-id-type="pmid">33668521</pub-id></mixed-citation>
              </ref>
              <ref id="B3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B</given-names></name><name><surname>Luderer</surname><given-names>U</given-names></name></person-group>. <article-title>Reproductive hazards of space travel in women and men.</article-title><source><italic>Nat Rev Endocrinol.</italic></source> (<year>2019</year>) <volume>15</volume>:<fpage>713</fpage>â€“<lpage>30</lpage>.<pub-id pub-id-type="pmid">31611649</pub-id></mixed-citation>
              </ref>
              <ref id="B4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>ZS</given-names></name><name><surname>Brunstetter</surname><given-names>TJ</given-names></name><name><surname>Tarver</surname><given-names>WJ</given-names></name><name><surname>Whitmire</surname><given-names>AM</given-names></name><name><surname>Zwart</surname><given-names>SR</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Red risks for a journey to the red planet: the highest priority human health risks for a mission to Mars.</article-title><source><italic>NPJ Microgravity.</italic></source> (<year>2020</year>) <volume>6</volume>:<fpage>1</fpage>â€“<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s41526-020-00124-6</pub-id>
<?supplied-pmid 33298950?><pub-id pub-id-type="pmid">31934612</pub-id></mixed-citation>
              </ref>
              <ref id="B5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garikipati</surname><given-names>VNS</given-names></name><name><surname>Shoja-Taheri</surname><given-names>F</given-names></name><name><surname>Davis</surname><given-names>ME</given-names></name><name><surname>Kishore</surname><given-names>R</given-names></name></person-group>. <article-title>Extracellular vesicles and the application of system biology and computational modeling in cardiac repair.</article-title><source><italic>Circ Res.</italic></source> (<year>2018</year>) <volume>123</volume>:<fpage>188</fpage>â€“<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311215</pub-id>
<?supplied-pmid 29976687?><pub-id pub-id-type="pmid">29976687</pub-id></mixed-citation>
              </ref>
              <ref id="B6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramowicz</surname><given-names>A</given-names></name><name><surname>Story</surname><given-names>MD</given-names></name></person-group>. <article-title>The long and short of it: the emerging roles of non-coding RNA in small extracellular vesicles.</article-title><source><italic>Cancers.</italic></source> (<year>2020</year>) <volume>12</volume>:<issue>1445</issue>. <pub-id pub-id-type="doi">10.3390/cancers12061445</pub-id>
<?supplied-pmid 32498257?><pub-id pub-id-type="pmid">32498257</pub-id></mixed-citation>
              </ref>
              <ref id="B7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Shao</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Lv</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Characterization of serum small extracellular vesicles and their small RNA contents across humans, rats, and mice.</article-title><source><italic>Sci Rep.</italic></source> (<year>2020</year>) <volume>10</volume>:<issue>4197</issue>. <pub-id pub-id-type="doi">10.1038/s41598-020-61098-9</pub-id>
<?supplied-pmid 32144372?><pub-id pub-id-type="pmid">32144372</pub-id></mixed-citation>
              </ref>
              <ref id="B8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name></person-group>. <article-title>More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair.</article-title><source><italic>Circ Res.</italic></source> (<year>2016</year>) <volume>118</volume>:<fpage>330</fpage>â€“<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.307654</pub-id>
<?supplied-pmid 26838317?><pub-id pub-id-type="pmid">26838317</pub-id></mixed-citation>
              </ref>
              <ref id="B9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Garikipati</surname><given-names>VN</given-names></name><name><surname>Verma</surname><given-names>SK</given-names></name><name><surname>Goukassian</surname><given-names>DA</given-names></name><name><surname>Kishore</surname><given-names>R</given-names></name></person-group>. <article-title>Interleukin-10 deficiency impairs reparative properties of bone marrow-derived endothelial progenitor cell exosome function.</article-title><source><italic>Tissue Eng Part A.</italic></source> (<year>2017</year>) <volume>23</volume>:<fpage>1241</fpage>â€“<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEA.2017.0084</pub-id>
<?supplied-pmid 28471299?><pub-id pub-id-type="pmid">28471299</pub-id></mixed-citation>
              </ref>
              <ref id="B10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Nickoloff</surname><given-names>E</given-names></name><name><surname>Abramova</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Verma</surname><given-names>SK</given-names></name><name><surname>Krishnamurthy</surname><given-names>P</given-names></name><etal/></person-group><article-title>Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.</article-title><source><italic>Circ Res.</italic></source> (<year>2015</year>) <volume>117</volume>:<fpage>52</fpage>â€“<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.305990</pub-id>
<?supplied-pmid 25904597?><pub-id pub-id-type="pmid">25904597</pub-id></mixed-citation>
              </ref>
              <ref id="B11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Garikipati</surname><given-names>VNS</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Benedict</surname><given-names>C</given-names></name><name><surname>Houser</surname><given-names>SR</given-names></name><name><surname>Koch</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Identification and comparison of hyperglycemia-induced extracellular vesicle transcriptome in different mouse stem cells.</article-title><source><italic>Cells.</italic></source> (<year>2020</year>) <volume>9</volume>:<issue>2098</issue>. <pub-id pub-id-type="doi">10.3390/cells9092098</pub-id>
<?supplied-pmid 32942572?><pub-id pub-id-type="pmid">32942572</pub-id></mixed-citation>
              </ref>
              <ref id="B12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisserier</surname><given-names>M</given-names></name><name><surname>Saffran</surname><given-names>N</given-names></name><name><surname>Brojakowska</surname><given-names>A</given-names></name><name><surname>Sebastian</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>AC</given-names></name><name><surname>Coleman</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Emerging role of exosomal long non-coding RNAs in spaceflight-associated risks in astronauts.</article-title><source><italic>Front Genet.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>812188</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2021.812188</pub-id>
<?supplied-pmid 35111205?><pub-id pub-id-type="pmid">35111205</pub-id></mixed-citation>
              </ref>
              <ref id="B13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Downregulation of snoRNA SNORA52 and its clinical significance in hepatocellular carcinoma.</article-title><source><italic>Biomed Res Int.</italic></source> (<year>2021</year>) <volume>2021</volume>:<issue>7020637</issue>. <pub-id pub-id-type="doi">10.1155/2021/7020637</pub-id>
<?supplied-pmid 34195281?><pub-id pub-id-type="pmid">34195281</pub-id></mixed-citation>
              </ref>
              <ref id="B14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>V</given-names></name><name><surname>Nizamudeen</surname><given-names>ZA</given-names></name><name><surname>Lea</surname><given-names>D</given-names></name><name><surname>Dottorini</surname><given-names>T</given-names></name><name><surname>Holmes</surname><given-names>TL</given-names></name><name><surname>Johnson</surname><given-names>BB</given-names></name><etal/></person-group><article-title>Transcriptomic analysis of cardiomyocyte extracellular vesicles in hypertrophic cardiomyopathy reveals differential snoRNA cargo.</article-title><source><italic>Stem Cells Dev.</italic></source> (<year>2021</year>) <volume>30</volume>:<fpage>1215</fpage>â€“<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2021.0202</pub-id>
<?supplied-pmid 34806414?><pub-id pub-id-type="pmid">34806414</pub-id></mixed-citation>
              </ref>
              <ref id="B15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schena</surname><given-names>GJ</given-names></name><name><surname>Murray</surname><given-names>EK</given-names></name><name><surname>Hildebrand</surname><given-names>AN</given-names></name><name><surname>Headrick</surname><given-names>AL</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Koch</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Cortical bone stem cell-derived exosomesâ€™ therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling.</article-title><source><italic>Am J Physiol Heart Circ Physiol.</italic></source> (<year>2021</year>) <volume>321</volume>:<fpage>H1014</fpage>â€“<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00197.2021</pub-id>
<?supplied-pmid 34623184?><pub-id pub-id-type="pmid">34623184</pub-id></mixed-citation>
              </ref>
              <ref id="B16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>X-P</given-names></name><name><surname>Zhang</surname><given-names>B-X</given-names></name><name><surname>Chu</surname><given-names>L</given-names></name></person-group>. <article-title>Small nucleolar RNAs: insight into their function in cancer.</article-title><source><italic>Front Oncol.</italic></source> (<year>2019</year>) <volume>9</volume>:<issue>587</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2019.00587</pub-id>
<?supplied-pmid 31338327?><pub-id pub-id-type="pmid">31338327</pub-id></mixed-citation>
              </ref>
              <ref id="B17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holley</surname><given-names>CL</given-names></name><name><surname>Topkara</surname><given-names>VK</given-names></name></person-group>. <article-title>An introduction to small non-coding RNAs: miRNA and snoRNA.</article-title><source><italic>Cardiovasc Drugs Ther.</italic></source> (<year>2011</year>) <volume>25</volume>:<fpage>151</fpage>â€“<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s10557-011-6290-z</pub-id>
<?supplied-pmid 21573765?><pub-id pub-id-type="pmid">21573765</pub-id></mixed-citation>
              </ref>
              <ref id="B18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorjani</surname><given-names>H</given-names></name><name><surname>Kehr</surname><given-names>S</given-names></name><name><surname>Jedlinski</surname><given-names>DJ</given-names></name><name><surname>Gumienny</surname><given-names>R</given-names></name><name><surname>Hertel</surname><given-names>J</given-names></name><name><surname>Stadler</surname><given-names>PF</given-names></name><etal/></person-group><article-title>An updated human snoRNAome.</article-title><source><italic>Nucleic Acids Res.</italic></source> (<year>2016</year>) <volume>44</volume>:<fpage>5068</fpage>â€“<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw386</pub-id>
<?supplied-pmid 27174936?><pub-id pub-id-type="pmid">27174936</pub-id></mixed-citation>
              </ref>
              <ref id="B19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>BA</given-names></name><name><surname>Ho</surname><given-names>HT</given-names></name><name><surname>Ranganathan</surname><given-names>SV</given-names></name><name><surname>Vangaveti</surname><given-names>S</given-names></name><name><surname>Ilkayeva</surname><given-names>O</given-names></name><name><surname>Abou Assi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Modification of messenger RNA by 2â€™-O-methylation regulates gene expression in vivo.</article-title><source><italic>Nat Commun.</italic></source> (<year>2019</year>) <volume>10</volume>:<issue>3401</issue>. <pub-id pub-id-type="doi">10.1038/s41467-019-11375-7</pub-id>
<?supplied-pmid 31363086?><pub-id pub-id-type="pmid">31363086</pub-id></mixed-citation>
              </ref>
              <ref id="B20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>P</given-names></name><name><surname>Kibiryeva</surname><given-names>N</given-names></name><name><surname>Uechi</surname><given-names>T</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Oâ€™brien</surname><given-names>JE</given-names><suffix>Jr.</suffix></name><name><surname>Artman</surname><given-names>M</given-names></name><etal/></person-group><article-title>scaRNAs regulate splicing and vertebrate heart development.</article-title><source><italic>Biochim Biophys Acta.</italic></source> (<year>2015</year>) <volume>1852</volume>:<fpage>1619</fpage>â€“<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2015.04.016</pub-id>
<?supplied-pmid 25916634?><pub-id pub-id-type="pmid">25916634</pub-id></mixed-citation>
              </ref>
              <ref id="B21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>AN</given-names></name><name><surname>Holley</surname><given-names>CL</given-names></name><name><surname>Mahadevan</surname><given-names>J</given-names></name><name><surname>Pyles</surname><given-names>KD</given-names></name><name><surname>Lavagnino</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Rpl13a small nucleolar RNAs regulate systemic glucose metabolism.</article-title><source><italic>J Clin Invest.</italic></source> (<year>2016</year>) <volume>126</volume>:<fpage>4616</fpage>â€“<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1172/JCI88069</pub-id>
<?supplied-pmid 27820699?><pub-id pub-id-type="pmid">27820699</pub-id></mixed-citation>
              </ref>
              <ref id="B22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baral</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Katwal</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>Q</given-names></name></person-group>. <article-title>Clinical significance and biological roles of small nucleolar RNAs in hepatocellular carcinoma.</article-title><source><italic>Biomed Rep.</italic></source> (<year>2018</year>) <volume>8</volume>:<fpage>319</fpage>â€“<lpage>24</lpage>. <pub-id pub-id-type="doi">10.3892/br.2018.1063</pub-id>
<?supplied-pmid 29541452?><pub-id pub-id-type="pmid">29541452</pub-id></mixed-citation>
              </ref>
              <ref id="B23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beneventi</surname><given-names>G</given-names></name><name><surname>Munita</surname><given-names>R</given-names></name><name><surname>Cao Thi Ngoc</surname><given-names>P</given-names></name><name><surname>Madej</surname><given-names>M</given-names></name><name><surname>Ciesla</surname><given-names>M</given-names></name><name><surname>Muthukumar</surname><given-names>S</given-names></name><etal/></person-group><article-title>The small Cajal body-specific RNA 15 (SCARNA15) directs p53 and redox homeostasis via selective splicing in cancer cells.</article-title><source><italic>NAR Cancer.</italic></source> (<year>2021</year>) <volume>3</volume>:<issue>zcab026</issue>. <pub-id pub-id-type="doi">10.1093/narcan/zcab026</pub-id>
<?supplied-pmid 34316713?><pub-id pub-id-type="pmid">34316713</pub-id></mixed-citation>
              </ref>
              <ref id="B24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Werf</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>CV</given-names></name><name><surname>Fleming</surname><given-names>NI</given-names></name></person-group>. <article-title>SnoRNA in cancer progression, metastasis and immunotherapy response.</article-title><source><italic>Biology.</italic></source> (<year>2021</year>) <volume>10</volume>:<issue>809</issue>. <pub-id pub-id-type="doi">10.3390/biology10080809</pub-id>
<?supplied-pmid 34440039?><pub-id pub-id-type="pmid">34440039</pub-id></mixed-citation>
              </ref>
              <ref id="B25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>PJ</given-names></name><name><surname>Perez</surname><given-names>CJ</given-names></name><name><surname>Adler</surname><given-names>KA</given-names></name><name><surname>Ziegler</surname><given-names>MG</given-names></name></person-group>. <article-title>The effects of spaceflight on adrenergic receptors and agonists and cell adhesion molecule expression.</article-title><source><italic>J Neuroimmunol.</italic></source> (<year>2002</year>) <volume>132</volume>:<fpage>173</fpage>â€“<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-5728(02)00313-2</pub-id>
<?supplied-pmid 12417448?><pub-id pub-id-type="pmid">12417448</pub-id></mixed-citation>
              </ref>
              <ref id="B26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisserier</surname><given-names>M</given-names></name><name><surname>Shanmughapriya</surname><given-names>S</given-names></name><name><surname>Rai</surname><given-names>AK</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Brojakowska</surname><given-names>A</given-names></name><name><surname>Garikipati</surname><given-names>VNS</given-names></name><etal/></person-group><article-title>Cell-Free mitochondrial DNA as a potential biomarker for Astronautsâ€™ health.</article-title><source><italic>J Am Heart Assoc.</italic></source> (<year>2021</year>) <volume>10</volume>:<issue>e022055</issue>.</mixed-citation>
              </ref>
              <ref id="B27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name></person-group>. <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads.</article-title><source><italic>EMBnet J.</italic></source> (<year>2011</year>) <volume>17</volume>:<fpage>10</fpage>â€“<lpage>2</lpage>. <pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></mixed-citation>
              </ref>
              <ref id="B28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group>. <article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.</article-title><source><italic>Genome Biol.</italic></source> (<year>2009</year>) <volume>10</volume>:<issue>R25</issue>. <pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id>
<?supplied-pmid 19261174?><pub-id pub-id-type="pmid">19261174</pub-id></mixed-citation>
              </ref>
              <ref id="B29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group>. <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.</article-title><source><italic>Bioinformatics.</italic></source> (<year>2014</year>) <volume>30</volume>:<fpage>923</fpage>â€“<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
<?supplied-pmid 24227677?><pub-id pub-id-type="pmid">24227677</pub-id></mixed-citation>
              </ref>
              <ref id="B30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risso</surname><given-names>D</given-names></name><name><surname>Ngai</surname><given-names>J</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group>. <article-title>Normalization of RNA-seq data using factor analysis of control genes or samples.</article-title><source><italic>Nat Biotechnol.</italic></source> (<year>2014</year>) <volume>32</volume>:<fpage>896</fpage>â€“<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2931</pub-id>
<?supplied-pmid 25150836?><pub-id pub-id-type="pmid">25150836</pub-id></mixed-citation>
              </ref>
              <ref id="B31">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>Mccarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group>. <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.</article-title><source><italic>Bioinformatics.</italic></source> (<year>2010</year>) <volume>26</volume>:<fpage>139</fpage>â€“<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id>
<?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
              </ref>
              <ref id="B32">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natchiar</surname><given-names>SK</given-names></name><name><surname>Myasnikov</surname><given-names>AG</given-names></name><name><surname>Kratzat</surname><given-names>H</given-names></name><name><surname>Hazemann</surname><given-names>I</given-names></name><name><surname>Klaholz</surname><given-names>BP</given-names></name></person-group>. <article-title>Visualization of chemical modifications in the human 80S ribosome structure.</article-title><source><italic>Nature.</italic></source> (<year>2017</year>) <volume>551</volume>:<fpage>472</fpage>â€“<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature24482</pub-id>
<?supplied-pmid 29143818?><pub-id pub-id-type="pmid">29143818</pub-id></mixed-citation>
              </ref>
              <ref id="B33">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bratkovic</surname><given-names>T</given-names></name><name><surname>Bozic</surname><given-names>J</given-names></name><name><surname>Rogelj</surname><given-names>B</given-names></name></person-group>. <article-title>Functional diversity of small nucleolar RNAs.</article-title><source><italic>Nucleic Acids Res.</italic></source> (<year>2020</year>) <volume>48</volume>:<fpage>1627</fpage>â€“<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz1140</pub-id>
<?supplied-pmid 31828325?><pub-id pub-id-type="pmid">31828325</pub-id></mixed-citation>
              </ref>
              <ref id="B34">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansson</surname><given-names>MD</given-names></name><name><surname>Hafner</surname><given-names>SJ</given-names></name><name><surname>Altinel</surname><given-names>K</given-names></name><name><surname>Tehler</surname><given-names>D</given-names></name><name><surname>Krogh</surname><given-names>N</given-names></name><name><surname>Jakobsen</surname><given-names>E</given-names></name><etal/></person-group><article-title>Regulation of translation by site-specific ribosomal RNA methylation.</article-title><source><italic>Nat Struct Mol Biol.</italic></source> (<year>2021</year>) <volume>28</volume>:<fpage>889</fpage>â€“<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1038/s41594-021-00669-4</pub-id>
<?supplied-pmid 34759377?><pub-id pub-id-type="pmid">34759377</pub-id></mixed-citation>
              </ref>
              <ref id="B35">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>T</given-names></name><name><surname>Taniuchi</surname><given-names>K</given-names></name><name><surname>Tsuboi</surname><given-names>M</given-names></name><name><surname>Sakaguchi</surname><given-names>M</given-names></name><name><surname>Kohsaki</surname><given-names>T</given-names></name><name><surname>Okabayashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer.</article-title><source><italic>Mol Oncol.</italic></source> (<year>2019</year>) <volume>13</volume>:<fpage>212</fpage>â€“<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1002/1878-0261.12398</pub-id>
<?supplied-pmid 30358104?><pub-id pub-id-type="pmid">30358104</pub-id></mixed-citation>
              </ref>
              <ref id="B36">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name></person-group>. <article-title>Knockdown of SNORA47 inhibits the tumorigenesis of NSCLC via mediation of PI3K/Akt signaling pathway.</article-title><source><italic>Front Oncol.</italic></source> (<year>2021</year>) <volume>11</volume>:<issue>620213</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2021.620213</pub-id>
<?supplied-pmid 33816250?><pub-id pub-id-type="pmid">33816250</pub-id></mixed-citation>
              </ref>
              <ref id="B37">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faucher-Giguere</surname><given-names>L</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Deschamps-Francoeur</surname><given-names>G</given-names></name><name><surname>Couture</surname><given-names>S</given-names></name><name><surname>Nottingham</surname><given-names>RM</given-names></name><name><surname>Lambowitz</surname><given-names>AM</given-names></name><etal/></person-group><article-title>High-grade ovarian cancer associated H/ACA snoRNAs promote cancer cell proliferation and survival.</article-title><source><italic>NAR Cancer.</italic></source> (<year>2022</year>) <volume>4</volume>:<issue>zcab050</issue>. <pub-id pub-id-type="doi">10.1093/narcan/zcab050</pub-id>
<?supplied-pmid 35047824?><pub-id pub-id-type="pmid">35047824</pub-id></mixed-citation>
              </ref>
              <ref id="B38">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oâ€™Brien</surname><given-names>JE</given-names><suffix>Jr.</suffix></name><name><surname>Kibiryeva</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>XG</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Lofland</surname><given-names>GK</given-names></name><name><surname>Artman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Noncoding RNA expression in myocardium from infants with tetralogy of Fallot.</article-title><source><italic>Circ Cardiovasc Genet.</italic></source> (<year>2012</year>) <volume>5</volume>:<fpage>279</fpage>â€“<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.111.961474</pub-id>
<?supplied-pmid 22528145?><pub-id pub-id-type="pmid">22528145</pub-id></mixed-citation>
              </ref>
              <ref id="B39">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname><given-names>KS</given-names></name><name><surname>Doniger</surname><given-names>T</given-names></name><name><surname>Cohen-Chalamish</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Semo</surname><given-names>O</given-names></name><name><surname>Aryal</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pseudouridines on Trypanosoma brucei spliceosomal small nuclear RNAs and their implication for RNA and protein interactions.</article-title><source><italic>Nucleic Acids Res.</italic></source> (<year>2019</year>) <volume>47</volume>:<fpage>7633</fpage>â€“<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz477</pub-id>
<?supplied-pmid 31147702?><pub-id pub-id-type="pmid">31147702</pub-id></mixed-citation>
              </ref>
              <ref id="B40">
                <label>40.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname><given-names>KS</given-names></name><name><surname>Adler</surname><given-names>K</given-names></name><name><surname>Madmoni</surname><given-names>H</given-names></name><name><surname>Peleg-Chen</surname><given-names>D</given-names></name><name><surname>Cohen-Chalamish</surname><given-names>S</given-names></name><name><surname>Doniger</surname><given-names>T</given-names></name><etal/></person-group><article-title>Pseudouridines on Trypanosoma brucei mRNAs are developmentally regulated: implications to mRNA stability and protein binding.</article-title><source><italic>Mol Microbiol.</italic></source> (<year>2021</year>) <volume>116</volume>:<fpage>808</fpage>â€“<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.14774</pub-id>
<?supplied-pmid 34165831?><pub-id pub-id-type="pmid">34165831</pub-id></mixed-citation>
              </ref>
              <ref id="B41">
                <label>41.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>XH</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Fournier</surname><given-names>MJ</given-names></name></person-group>. <article-title>rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity.</article-title><source><italic>Mol Cell.</italic></source> (<year>2007</year>) <volume>28</volume>:<fpage>965</fpage>â€“<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.10.012</pub-id>
<?supplied-pmid 18158895?><pub-id pub-id-type="pmid">18158895</pub-id></mixed-citation>
              </ref>
              <ref id="B42">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>XH</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Fournier</surname><given-names>MJ</given-names></name></person-group>. <article-title>Loss of rRNA modifications in the decoding center of the ribosome impairs translation and strongly delays pre-rRNA processing.</article-title><source><italic>RNA.</italic></source> (<year>2009</year>) <volume>15</volume>:<fpage>1716</fpage>â€“<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1261/rna.1724409</pub-id>
<?supplied-pmid 19628622?><pub-id pub-id-type="pmid">19628622</pub-id></mixed-citation>
              </ref>
              <ref id="B43">
                <label>43.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikne</surname><given-names>V</given-names></name><name><surname>Doniger</surname><given-names>T</given-names></name><name><surname>Rajan</surname><given-names>KS</given-names></name><name><surname>Bartok</surname><given-names>O</given-names></name><name><surname>Eliaz</surname><given-names>D</given-names></name><name><surname>Cohen-Chalamish</surname><given-names>S</given-names></name><etal/></person-group><article-title>A pseudouridylation switch in rRNA is implicated in ribosome function during the life cycle of Trypanosoma brucei.</article-title><source><italic>Sci Rep.</italic></source> (<year>2016</year>) <volume>6</volume>:<issue>25296</issue>. <pub-id pub-id-type="doi">10.1038/srep25296</pub-id>
<?supplied-pmid 27142987?><pub-id pub-id-type="pmid">27142987</pub-id></mixed-citation>
              </ref>
              <ref id="B44">
                <label>44.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcel</surname><given-names>V</given-names></name><name><surname>Kielbassa</surname><given-names>J</given-names></name><name><surname>Marchand</surname><given-names>V</given-names></name><name><surname>Natchiar</surname><given-names>KS</given-names></name><name><surname>Paraqindes</surname><given-names>H</given-names></name><name><surname>Nguyen Van Long</surname><given-names>F</given-names></name><etal/></person-group><article-title>Ribosomal RNA 2â€™O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.</article-title><source><italic>NAR Cancer.</italic></source> (<year>2020</year>) <volume>2</volume>:<issue>zcaa036</issue>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
